122P - Different efficacy between two erythropoiesis-stimulating agents (ESAs) for chemotherapy-induced anaemia (CIA) treatment in patients with non-small...
|Date||28 March 2014|
|Session||Lunch and poster display session|
|Topics|| Supportive Care
Lung and other Thoracic Tumours
|Presenter||Analia Rodriguez Garzotto|
|Citation||Journal of Thoracic Oncology (2014) 9 (Supplement 9): S7-S52. 10.1097/JTO.0000000000000131|
A. Rodriguez Garzotto1, S. Cortijo2, C. Pernaut1, I. Otero1, G. Ruiz Ares1, L. Parrilla1, M. Blazquez Arroyo1, J. Zugazagoitia1, S. Ponce Aix1
There are limited data on the relative effectiveness of biosimilar ESAs and other available ESAs for the treatment of CIA. In addition, it is unclear whether the most recent recommendations for more conservative use of ESAs to treat CIA are reflected in real-world clinical practice.